BCL2 and neoplasm: Interestingly, one of these genes (BCL2) showed significantly decreased levels of mRNA in one tumor and significantly increased mRNA levels in one other of the three tumor samples tested here, whilst the other two genes showed significant and very strong upregulation in three out of three tumors (PDGFRB) or two out of three tumors tested (TSC2).